At present, ChAc disease has no specific treatment, medications (such as dopamine blockers and VMAT2 inhibitors) can improve dyskinesia or rather chorea significantly, however not all of the symptoms of ChAc respond, and there may be side effects. Here, SLC18A2 is linked to chorea-acanthocytosis.